At 7.0% CAGR, the North America Capnography Equipment Market is projected to be worth US$ 302.81 million by 2028, says Business Market Insights              

According to Business Market Insights’ research, the North America capnography equipment market was valued at US$ 201.81 million in 2022 and is expected to reach US$ 302.81 million by 2028, registering an annual growth rate of 7.0% from 2022 to 2028.  Clinical benefits of capnography equipment over pulse oximetry and prevalence of respiratory disorders are the critical factors attributed to the market expansion.                

Pulse oximetry is a technique used to measure the oxygen level/saturation of the blood. The oxygen level is detected with the use of infrared and red light to determine the extent of oxygenation of hemoglobin. On the other hand, in capnography, CO2 absorbs infrared radiation, and thus, the procedure involves the passage of infrared radiation over a gas sample collected from exhalation. In many cases, oxygen levels in the blood can remain normal for several minutes after a patient stops breathing. Therefore, pulse oximetry can provide false positive results of the presence of oxygen in the blood. As capnography detects the CO2 present in the body, the detection is more accurate than pulse oximetry. The equipment can read every phase of the respiratory cycle, thereby providing more in-depth readings than those offered by pulse oximetry monitors. The ability of capnography machines to provide robust data sets makes it easier for healthcare providers to diagnose the root causes of respiratory problems. The capnograph wavelength displays the entire breathing cycle, making it easier to track exact symptoms. Capnography is used to understand how a patient is responding to treatment as they can display the ongoing data in real time. They can also be used to determine when a patient should be ventilated, in case of a patient progressing to respiratory failure. Pulse oximetry cannot detect respiratory conditions as they do not provide any data in real time. This, the advantages of capnography equipment over pulse oximetry are fueling the growth of the market.

On the contrary, stringent regulations for approval of capnography equipment hurdles the growth of North America capnography equipment market.    

• Based on product type, the North America capnography equipment market is segmented into capnometer and capnography accessories & disposables. The capnography accessories & disposables segment held 53.1% market share in 2022, amassing US$ 107.21 million. It is projected to garner US$ 160.55 million by 2028 to expand at 7.0% CAGR during 2022–2028.  
• Based on technology, the North America capnography equipment market is segmented into mainstream capnography, sidestream capnography, and microstream capnography. The mainstream capnography segment held 56.0% market share in 2022, amassing US$ 112.92 million. It is projected to garner US$ 168.65 million by 2028 to expand at 6.9% CAGR during 2022–2028.
• Based on application, the North America capnography equipment market is segmented into cardiac care, trauma and emergency care, procedural sedation, respiratory monitoring, and others. The cardiac care segment held 38.7% market share in 2022, amassing US$ 78.19 million. It is projected to garner US$ 116.92 million by 2028 to expand at 6.9% CAGR during 2022–2028.
• Based on end user, the North America capnography equipment market is segmented into hospitals, ambulatory surgery center, home care settings, and others. The hospitals segment held 60.5% market share in 2022, amassing US$ 122.18 million. It is projected to garner US$ 182.27 million by 2028 to expand at 6.9% CAGR during 2022–2028.
• Based on country, the North America capnography equipment market is segmented into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.3% market share in 2022. It was assessed at US$ 168.06 million in 2022 and is likely to hit US$ 251.97 million by 2028, exhibiting a CAGR of 7.0% during the forecast period.    

Key players dominating the North America capnography equipment market are BD, Dragerwerk AG & Co. KGaA, General Electric Company, Hill Rom Holding Inc. (Baxter), ICU Medical Inc., Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, and SCHILLER Americas Inc. among others.  

• In July 2020, Welch Allyn (Hill Rom Holdings, Inc.) announced new product launch namely, "Connex® Vital Signs Monitor" that has intuitive touchscreen that is adaptable for most low-acuity healthcare environments and clinical workflows. The product can also track cardiac activity using 3-or-5 lead ECG monitoring, measure pulse oximeter, non-invasive blood pressure (NIBP), temperature, end-tidal CO2 (EtCO2), respiration, and many more.

• In May 2020, Philips announced partnership with Masimo for integrating measurement technologies into few of its IntelliVue MX-series multi-parameter monitors to help assess cerebral oximetry and ventilation status.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com